- Filed
- May 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 12, 2026 | 11.46M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 628.53K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 42.76K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.12M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$2M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $11.75M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $15.76M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $3.99M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $8.54M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.07M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $9.14M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.08M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $9.16M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $4.33M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.07M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $14.83M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $24.93M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$6.71 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$227.25 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$6.71 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$227.25 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.04M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.67M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$4.21M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$8.55M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$10.23M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$12.57M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$1.66K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $45.83K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $23.11K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $55.8K |